1990 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum

Ferreri, A. J. M., Sassone, M., Miserocchi, E., Govi, S., Cecchetti, C., Corti, M. E., Mappa, S., Arcaini, L., Zaja, F., Todeschini, G., Mannina, D., Calimeri, T., Perrone, S., Ponzoni, M. & Modorati, G., Mar 24 2020, In : Blood advances. 4, 6, p. 1013-1019 7 p.

Research output: Contribution to journalArticle

Open Access
2019

Applying data warehousing to a phase III clinical trial from the Fondazione Italiana Linfomi ensures superior data quality and improved assessment of clinical outcomes

Zaccaria, G. M., Ferrero, S., Rosati, S., Ghislieri, M., Genuardi, E., Evangelista, A., Sandrone, R., Castagneri, C., Barbero, D., Schirico, M. L., Arcaini, L., Molinari, A. L., Ballerini, F., Ferreri, A., Omedè, P., Zamò, A., Balestra, G., Boccadoro, M., Cortelazzo, S. & Ladetto, M., Jan 1 2019, In : JCO clinical cancer informatics. 3

Research output: Contribution to journalArticle

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma

Grommes, C., Rubenstein, J. L., DeAngelis, L. M., Ferreri, A. J. M. & Batchelor, T. T., Jan 1 2019, In : Neuro-Oncology. 21, 3, p. 296-305 10 p.

Research output: Contribution to journalArticle

Diagnostic and Clinical Impact of Staging 18F-FDG PET/CT in Mantle-Cell Lymphoma: A Two-Center Experience

Albano, D., Ferro, P., Bosio, G., Fallanca, F., Re, A., Tucci, A., Maria Ferreri, A. J., Angelillo, P., Gianolli, L., Giubbini, R. & Bertagna, F., Aug 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 8, p. e457-e464

Research output: Contribution to journalArticle

Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL

Xu-Monette, Z. Y., Xiao, M., Au, Q., Padmanabhan, R., Xu, B., Hoe, N., Rodríguez-Perales, S., Torres-Ruiz, R., Manyam, G. C., Visco, C., Miao, Y., Tan, X., Zhang, H., Tzankov, A., Wang, J., Dybkær, K., Tam, W., You, H., Bhagat, G., Hsi, E. D. & 13 others, Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Han van Krieken, J., Winter, J. N., Westin, J. R., Pham, L. V., Jeffrey Medeiros, L., Rassidakis, G. Z., Li, Y., Freeman, G. J. & Young, K. H., Apr 2019, In : Cancer immunology research. 7, 4, p. 644-657 14 p.

Research output: Contribution to journalArticle

Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

Xu-Monette, Z. Y., Li, J., Xia, Y., Crossley, B., Bremel, R. D., Miao, Y., Xiao, M., Snyder, T., Manyam, G. C., Tan, X., Zhang, H., Visco, C., Tzankov, A., Dybkaer, K., Bhagat, G., Tam, W., You, H., Hsi, E. D., Van Krieken, J. H., Huh, J. & 10 others, Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Winter, J. N., Medeiros, J. T., Xu, B., Li, Y., Kirsch, I. & Young, K. H., Oct 22 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 272.

Research output: Contribution to journalArticle

Open Access

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study

Ferrero, S., Rossi, D., Rinaldi, A., Bruscaggin, A., Spina, V., Eskelund, C. W., Evangelista, A., Moia, R., Kwee, I., Dahl, C., Di Rocco, A., Stefoni, V., Diop, F., Favini, C., Ghione, P., Mahmoud, A. M., Schipani, M., Kolstad, A., Barbero, D., Novero, D. & 13 others, Paulli, M., Zamò, A., Jerkeman, M., Gomez da Silva, M., Santoro, A., Molinari, A., Ferreri, A., Grønbæk, K., Piccin, A., Cortelazzo, S., Bertoni, F., Ladetto, M. & Gaidano, G., Sep 19 2019, In : Haematologica.

Research output: Contribution to journalArticle

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

“Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup), Apr 2019, In : Hematological Oncology. 37, 2, p. 160-167 8 p.

Research output: Contribution to journalArticle

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

on behalf of the “Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup), Jan 1 2019, In : Hematological Oncology.

Research output: Contribution to journalArticle

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

Rattotti, S., Ferretti, V. V., Rusconi, C., Rossi, A., Fogazzi, S., Baldini, L., Pioltelli, P., Balzarotti, M., Farina, L., Ferreri, A. J. M., Laszlo, D., Speziale, V., Varettoni, M., Sciarra, R., Morello, L., Tedeschi, A., Frigeni, M., Defrancesco, I., Zerbi, C., Flospergher, E. & 4 others, Nizzoli, M. E., Morra, E., Arcaini, L. & Workgroup), O. B. O. T. R. E. L. REL. . H. C. N. O. L. . L., 2019, In : Hematological Oncology. 37, 2, p. 160-167 8 p.

Research output: Contribution to journalArticle

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

Rattotti, S., Ferretti, V. V., Rusconi, C., Rossi, A., Fogazzi, S., Baldini, L., Pioltelli, P., Balzarotti, M., Farina, L., Ferreri, A. J. M., Laszlo, D., Speziale, V., Varettoni, M., Sciarra, R., Morello, L., Tedeschi, A., Frigeni, M., Defrancesco, I., Zerbi, C., Flospergher, E. & 4 others, Nizzoli, M. E., Morra, E., Arcaini, L. & Workgroup), O. B. O. T. R. E. L. REL. . H. C. N. O. L. . L., 2019, In : Hematological Oncology. 37, 2, p. 160-167 8 p.

Research output: Contribution to journalArticle

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

Rattotti, S., Ferretti, V. V., Rusconi, C., Rossi, A., Fogazzi, S., Baldini, L., Pioltelli, P., Balzarotti, M., Farina, L., Ferreri, A. J. M., Laszlo, D., Speziale, V., Varettoni, M., Sciarra, R., Morello, L., Tedeschi, A., Frigeni, M., Defrancesco, I., Zerbi, C., Flospergher, E. & 4 others, Nizzoli, M. E., Morra, E., Arcaini, L. & Workgroup), O. B. O. T. R. E. L. REL. . H. C. N. O. L. . L., 2019, In : Hematological Oncology. 37, 2, p. 160-167

Research output: Contribution to journalArticle

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

Rattotti, S., Ferretti, V. V., Rusconi, C., Rossi, A., Fogazzi, S., Baldini, L., Pioltelli, P., Balzarotti, M., Farina, L., Ferreri, A. J. M., Laszlo, D., Speziale, V., Varettoni, M., Sciarra, R., Morello, L., Tedeschi, A., Frigeni, M., Defrancesco, I., Zerbi, C., Flospergher, E. & 4 others, Nizzoli, M. E., Morra, E., Arcaini, L. & Workgroup), O. B. O. T. R. E. L. REL. . H. C. N. O. L. . L., 2019, In : Hematological Oncology.

Research output: Contribution to journalArticle

MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA

Miserocchi, E., Ferreri, A. J. M., Giuffrè, C., Cangi, M. G., Francaviglia, I., Calimeri, T., Ponzoni, M., Pecciarini, L., Bandello, F. M. & Modorati, G. M., Apr 1 2019, In : Retina. 39, 4, p. 679-684 6 p.

Research output: Contribution to journalArticle

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program

Li, L., Sun, R., Miao, Y., Tran, T., Adams, L., Roscoe, N., Xu, B., Manyam, G. C., Tan, X., Zhang, H., Xiao, M., Tzankov, A., Visco, C., Dybkaer, K., Bhagat, G., Tam, W., Hsi, E. D., van Krieken, J. H., You, H., Huh, J. & 13 others, Ponzoni, M., Ferreri, A. J. M., Møller, M. B., Piris, M. A., Zhang, M., Winter, J. N., Medeiros, L. J., Rassidakis, G. Z., Vaupel, C. A., Li, Y., Dakappagari, N., Xu-Monette, Z. Y. & Young, K. H., Jun 1 2019, In : Modern Pathology. 32, 6, p. 741-754 14 p.

Research output: Contribution to journalArticle

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-a in primary CNS lymphoma

Ferreri, A. J. M., Calimeri, T., Conte, G. M., Cattaneo, D., Fallanca, F., Ponzoni, M., Scarano, E., Curnis, F., Nonis, A., Lopedote, P., Citterio, G., Politi, L. S., Foppoli, M., Girlanda, S., Sassone, M., Perrone, S., Cecchetti, C., Ciceri, F., Bordignon, C., Corti, A. & 1 others, Anzalone, N., Jul 18 2019, In : Blood. 134, 3, p. 252-262 11 p.

Research output: Contribution to journalArticle

Rituximab in primary central nervous system lymphoma—A systematic review and meta-analysis

Schmitt, A. M., Herbrand, A. K., Fox, C. P., Bakunina, K., Bromberg, J. E. C., Cwynarski, K., Doorduijn, J. K., Ferreri, A. J. M., Illerhaus, G., Issa, S., Schorb, E., Zucca, E., Hemkens, L. G., Schandelmaier, S. & Kasenda, B., Dec 1 2019, In : Hematological Oncology. 37, 5, p. 548-557 10 p.

Research output: Contribution to journalReview article

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Swiss Group for Clinical Cancer Research and the Nordic Lymphoma Group, Jul 25 2019, In : Blood. 134, 4, p. 353-362 10 p.

Research output: Contribution to journalArticle

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Zucca, E., Rondeau, S., Vanazzi, A., Østenstad, B., Mey, UJM., Rauch, D., Wahlin, BE., Hitz, F., Hernberg, M., Johansson, AS., de Nully Brown, P., Hagberg, H., Ferreri, AJM., Lohri, A., Novak, U., Zander, T., Bersvendsen, H., Bargetzi, M., Mingrone, W., Krasniqi, F. & 8 others, Dirnhofer, S., Hayoz, S., Hawle, H., Vilei, SB., Ghielmini, M., Kimby, E., Research, F. T. S. G. F. C. C. & Group, T. N. L., 2019, In : Blood. 134, 4, p. 353-362 10 p.

Research output: Contribution to journalArticle

2018

Challenges and prospects in the diagnosis and treatment of primary central nervous system lymphoma

Citterio, G., Calimeri, T. & Ferreri, AJM., 2018, In : Expert Review of Neurotherapeutics. 18, 5, p. 379-393 15 p.

Research output: Contribution to journalArticle

Clarithromycin as a "repurposing drug" against MALT lymphoma

Ferreri, AJM., Cecchetti, C., Kiesewetter, B., Sassone, M., Calimeri, T., Perrone, S., Ponzoni, M. & Raderer, M., 2018, In : British Journal of Haematology. 182, 6, p. 913-915 3 p.

Research output: Contribution to journalArticle

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma

Wang, X., Cao, X., Sun, R., Tang, C., Tzankov, A., Zhang, J., Manyam, GC., Xiao, M., Miao, Y., Jabbar, K., Tan, X., Pang, Y., Visco, C., Xie, Y., Dybkaer, K., Chiu, A., Orazi, A., Zu, Y., Bhagat, G., Richards, KL. & 16 others, Hsi, ED., Choi, WWL., van Krieken, JH., Huh, J., Ponzoni, M., Ferreri, AJM., Møller, MB., Parsons, BM., Winter, JN., Piris, MA., Li, S., Miranda, RN., Medeiros, LJ., Li, Y., Xu-Monette, ZY. & Young, KH., 2018, In : Neoplasia (United States). 20, 6, p. 574-593 20 p.

Research output: Contribution to journalArticle

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy

Yao, Z., Deng, L., Xu-Monette, ZY., Manyam, GC., Jain, P., Tzankov, A., Visco, C., Bhagat, G., Wang, J., Dybkaer, K., Tam, W., Hsi, ED., van Krieken, JH., Ponzoni, M., Ferreri, AJM., Møller, MB., Winter, JN., Piris, MA., Fayad, L., Liu, Y. & 7 others, Song, Y., Orlowski, RZ., Kantarjian, H., Medeiros, LJ., Li, Y., Cortes, J. & Young, KH., 2018, In : Leukemia. 32, 2, p. 353-363 11 p.

Research output: Contribution to journalArticle

Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mule, A., Picardi, M., Romano, A., Cantonetti, M., Nasa, G. L., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, A. J. M., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, A. M. & Rambaldi, A., Feb 10 2018, In : Journal of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mulé, A., Picardi, M., Romano, A., Cantonetti, M., La Nasa, G., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, A. J. M., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, A. M. & Rambaldi, A., Feb 10 2018, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mule, A., Picardi, M., Romano, A., Cantonetti, M., Nasa, G. L., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, A. J. M., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, A. M. & Rambaldi, A., 2018, In : Journal of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Gallamini, A., Tarella, C., Viviani, S., Rossi, A., Patti, C., Mulé, A., Picardi, M., Romano, A., Cantonetti, M., La Nasa, G., Trentin, L., Bolis, S., Rapezzi, D., Battistini, R., Gottardi, D., Gavarotti, P., Corradini, P., Cimminiello, M., Schiavotto, C., Parvis, G. & 18 others, Zanotti, R., Gini, G., Ferreri, AJM., Viero, P., Miglino, M., Billio, A., Avigdor, A., Biggi, A., Fallanca, F., Ficola, U., Gregianin, M., Chiaravalloti, A., Prosperini, G., Bergesio, F., Chauvie, S., Pavoni, C., Gianni, AM. & Rambaldi, A., 2018, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36, 5, p. 454-462 9 p.

Research output: Contribution to journalArticle

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Iannitto, E., Bellei, M., Amorim, S., Ferreri, A. J. M., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse-Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, A. M., Merli, M. & 11 others, Gini, G., Cabras, M. G., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M. & Thieblemont, C., 2018, In : British Journal of Haematology. 183, 5, p. 755-765 11 p.

Research output: Contribution to journalArticle

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Iannitto, E., Bellei, M., Amorim, S., Ferreri, A. J. M., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse-Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, A. M., Merli, M. & 11 others, Gini, G., Cabras, M. G., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M. & Thieblemont, C., Dec 2018, In : British Journal of Haematology. 183, 5, p. 755-765 11 p.

Research output: Contribution to journalArticle

Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

Iannitto, E., Bellei, M., Amorim, S., Ferreri, AJM., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse-Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, AM., Merli, M. & 11 others, Gini, G., Cabras, MG., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M. & Thieblemont, C., 2018, In : British Journal of Haematology. 183, 5, p. 755-765 11 p.

Research output: Contribution to journalArticle

ESMO Consensus Conference on malignant lymphoma: General perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

& the ESMO Lymphoma Consensus Conference Panel Members, Mar 1 2018, In : Annals of Oncology. 29, 3, p. 544-562 19 p.

Research output: Contribution to journalArticle

ESMO consensus conference on Malignant lymphoma: Management of ‘ultra-high-risk’ patients

Hutchings, M., Ladetto, M., Buske, C., De Nully Brown, P., Ferreri, AJM., Pfreundschuh, M., Schmitz, N., Sureda Balari, A., Van Imhoff, G., Walewski, J. & Members, T. ESMO. L. C. C. P., 2018, In : Annals of Oncology. 29, 8, p. 1687-1700 14 p.

Research output: Contribution to journalArticle

Long-Term results of the FOLL05 trial comparing R-CVP Versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage symptomatic follicular lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, A. J. M., Vallisa, D., Marcheselli, L. & Federico, M., Mar 1 2018, In : Journal of Clinical Oncology. 36, 7, p. 689-696 8 p.

Research output: Contribution to journalArticle

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, A. J. M., Vallisa, D., Marcheselli, L. & Federico, M., Mar 1 2018, In : Journal of Clinical Oncology. 36, 7, p. 689-696 8 p.

Research output: Contribution to journalArticle

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Luminari, S., Ferrari, A., Manni, M., Dondi, A., Chiarenza, A., Merli, F., Rusconi, C., Tarantino, V., Tucci, A., Vitolo, U., Kovalchuk, S., Angelucci, E., Pulsoni, A., Arcaini, L., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F. & 4 others, Ferreri, AJM., Vallisa, D., Marcheselli, L. & Federico, M., 2018, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36, 7, p. 689-696 8 p.

Research output: Contribution to journalArticle

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma

Ceriani, L., Milan, L., Martelli, M., Ferreri, AJM., Cascione, L., Zinzani, PL., Di Rocco, A., Conconi, A., Stathis, A., Cavalli, F., Bellei, M., Cozens, K., Porro, E., Giovanella, L., Johnson, PW. & Zucca, E., 2018, In : Blood. 132, 2, p. 179-186 8 p.

Research output: Contribution to journalArticle

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., Feb 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., Feb 1 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, AJM., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, EA., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Luminari, S., Viel, E., Ferreri, A. J. M., Zaja, F., Chimienti, E., Musuraca, G., Tucci, A., Balzarotti, M., Tani, M., Salvi, F., Pesce, E. A., Ferrari, A., Liberati, A. M., Spadea, A., Marino, D., Bruno-Ventre, M., Volpetti, S., Bottelli, C., Ravaioli, E., Merli, F. & 1 others, Spina, M., 2018, In : Hematological Oncology. 36, 1, p. 68-75 8 p.

Research output: Contribution to journalArticle

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

El-Galaly, TC., Cheah, CY., Bendtsen, MD., Nowakowski, GS., Kansara, R., Savage, KJ., Connors, JM., Sehn, LH., Goldschmidt, N., Shaulov, A., Farooq, U., Link, BK., Ferreri, AJM., Calimeri, T., Cecchetti, C., Dann, EJ., Thompson, CA., Inbar, T., Maurer, MJ., Gade, IL. & 14 others, Juul, MB., Hansen, JW., Holmberg, S., Larsen, TS., Cordua, S., Mikhaeel, NG., Hutchings, M., Seymour, JF., Clausen, MR., Smith, D., Opat, S., Gilbertson, M., Thanarajasingam, G. & Villa, D., 2018, In : European Journal of Cancer. 93, 4, p. 57-68 12 p.

Research output: Contribution to journalArticle

2017

AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma

Wang, J., Xu-Monette, ZY., Jabbar, KJ., Shen, Q., Manyam, GC., Tzankov, A., Visco, C., Montes-Moreno, S., Dybkær, K., Tam, W., Bhagat, G., Hsi, ED., van Krieken, JH., Ponzoni, M., Ferreri, AJM., Wang, S., Møller, MB., Piris, MA., Medeiros, LJ., Li, Y. & 2 others, Pham, LV. & Young, KH., 2017, In : American Journal of Pathology. 187, 8, p. 1700-1716 17 p.

Research output: Contribution to journalArticle

Bacteria associated with marginal zone lymphomas

Ponzoni, M. & Ferreri, AJM., 2017, In : Best Practice and Research: Clinical Haematology. 30, 1-2, p. 32-40 9 p.

Research output: Contribution to journalArticle

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Guillermo, A. L., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, A. J. M., Zachée, P., Bosly, A. & 11 others, Haioun, C., Stelitano, C., Bellei, M., Ponzoni, M., Moreau, A., Jack, A., Campo, E., Mazzucchelli, L., Cavalli, F., Johnson, P. & Thieblemont, C., Jun 10 2017, In : Journal of Clinical Oncology. 35, 17, p. 1905-1912 8 p.

Research output: Contribution to journalArticle

Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Lopez Guillermo, A., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, A. J., Zachée, P., Bosly, A. & 11 others, Haioun, C., Stelitano, C., Bellei, M., Ponzoni, M., Moreau, A., Jack, A., Campo, E., Mazzucchelli, L., Cavalli, F., Johnson, P. & Thieblemont, C., 2017, In : Journal of Clinical Oncology. 35, 17, p. 1905-1912 8 p.

Research output: Contribution to journalArticle

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Guillermo, AL., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, AJM., Zachée, P., Bosly, A. & 11 others, Haioun, C., Stelitano, C., Bellei, M., Ponzoni, M., Moreau, A., Jack, A., Campo, E., Mazzucchelli, L., Cavalli, F., Johnson, P. & Thieblemont, C., 2017, In : Journal of Clinical Oncology. 35, 17, p. 1905-1912 8 p.

Research output: Contribution to journalArticle

Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations

Visco, C., Wang, J., Tisi, MC., Deng, L., d'Amore, E. S. G., Tzankov, A., Montes-Moreno, S., Dybkær, K., Bhagat, G., Hsi, ED., Van Krieken, JH., Ponzoni, M., Ferreri, AJM., Møller, MB., Piris, MA., Medeiros, LJ., Xu-Monette, ZY. & Young, KH., 2017, In : British Journal of Cancer. 117, 11, p. 1685-1688 4 p.

Research output: Contribution to journalArticle

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial

Ferreri, A. J. M., Sassone, M., Zaja, F., Re, A., Spina, M., Rocco, A. D., Fabbri, A., Stelitano, C., Frezzato, M., Rusconi, C., Zambello, R., Couto, S., Ren, Y., Arcari, A., Bertoldero, G., Nonis, A., Scarfò, L., Calimeri, T., Cecchetti, C., Chiozzotto, M. & 2 others, Govi, S. & Ponzoni, M., Mar 1 2017, In : The Lancet Haematology. 4, 3, p. e137-e146 9 p.

Research output: Contribution to journalArticle

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial

Ferreri, A. J. M., Sassone, M., Zaja, F., Re, A., Spina, M., Rocco, A. D., Fabbri, A., Stelitano, C., Frezzato, M., Rusconi, C., Zambello, R., Couto, S., Ren, Y., Arcari, A., Bertoldero, G., Nonis, A., Scarfò, L., Calimeri, T., Cecchetti, C., Chiozzotto, M. & 2 others, Govi, S. & Ponzoni, M., Mar 1 2017, In : The Lancet Haematology. 4, 3, p. e137-e146

Research output: Contribution to journalArticle

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial

Ferreri, AJM., Sassone, M., Zaja, F., Re, A., Spina, M., Rocco, AD., Fabbri, A., Stelitano, C., Frezzato, M., Rusconi, C., Zambello, R., Couto, S., Ren, Y., Arcari, A., Bertoldero, G., Nonis, A., Scarfò, L., Calimeri, T., Cecchetti, C., Chiozzotto, M. & 2 others, Govi, S. & Ponzoni, M., 2017, In : The Lancet Haematology. 4, 3, p. e137-e146

Research output: Contribution to journalArticle